Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Business Exposures
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Why ENT-Focused OptiNose Shares Are Diving Today
Via Benzinga
Exposures Product Safety
Tickers OPTN
Novartis' Rare Blood Disorder Therapy Scores FDA Approval
Via Benzinga
Exposures Product Safety
Tickers NVS
Adaptimmune Completes Submission of Rolling Biologics License Application (BLA) to U.S. FDA for Afami-cel for the Treatment of Advanced Synovial Sarcoma
Via Newsfile
Exposures Product Safety
Tickers ADAP
Actuated Medical Expands Expertise in Forensic DNA Analysis with Acquisition of Mitotyping Technologies LLC
Via PRLog
Topics Intellectual Property
Exposures COVID-19 Intellectual Property Product Safety
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Outlook Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - OTLK
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal Product Safety
Tickers OTLK
Pacific Sands Educates on Alcohol Blackouts
Via Press Advantage
Topics Product Recall
Exposures Legal Product Safety
Theralase makes positive progress on Phase II study on bladder cancer; targets breakthrough designation with FDA
Via News Direct
Exposures Product Safety
Theralase makes positive progress on Phase II study on bladder cancer; targets breakthrough designation with FDA
Via TheNewswire.com
Exposures Product Safety
89bio Outlines Roadmap For Pivotal Studies For Lead Program In Fatty Liver Disease
Via Benzinga
Exposures Product Safety
Tickers ETNB
ExoAtlet Unveils Groundbreaking ExoAtlet 2 and Industry-First Pediatric Exoskeleton
Via Press Release Distribution Service
Exposures Product Safety
Ozempic vs. Mounjaro:: Battle of the bulge
Via MarketBeat
Exposures Product Safety
Tickers HIMS LLY NVO PFE
FDA Grants Second Conditional Approval For Eli Lilly's Rare Blood Cancer Drug
Via Benzinga
Exposures Product Safety
Tickers LLY
Why Is Chronic Disease Focused Biora Therapeutics Stock Trading Higher Today?
Via Benzinga
Exposures Product Safety
Tickers BIOR
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM Encourages Outlook Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - OTLK
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal Product Safety
Tickers OTLK
Revolutionizing gastroparesis treatment: Evoke Pharma's CEO talks game-changing nasal spray
Via News Direct
Topics Intellectual Property
Exposures Intellectual Property Product Safety
Revolutionizing gastroparesis treatment: Evoke Pharma's CEO talks game-changing nasal spray
Via TheNewswire.com
Topics Intellectual Property
Exposures Intellectual Property Product Safety
Why Is This Rare Disease-Focused Soligenix Stock Trading Over 200% Today?
Via Benzinga
Exposures Product Safety
Tickers SNGX
InvestorNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Announces Participation in December MedInvest Oncology Investor Conference
Via Investor Brand Network
Exposures Product Safety
Tickers PCSA
Why Is Soligenix (SNGX) Stock Up 285% Today?
Via InvestorPlace
Exposures Product Safety
Tickers IMGN MINM QS SNGX
InvestorNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) CEO Discussed ‘Breakthrough’ FDA Clearance in Proactive Interview
Via Investor Brand Network
Exposures Product Safety
Tickers VVOS
ROSEN, A LEADING AND RANKED FIRM, Encourages SCYNEXIS, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SCYX
Via NewMediaWire
Topics Lawsuit Product Recall
Exposures Financial Legal Product Safety
Tickers SCYX
Cannabis Mold Alert In Arizona, California Nears $5.5B Tax Milestone, Search For Marijuana Breathalyzer
Via Benzinga
Topics Cannabis Product Recall
Exposures Cannabis Legal Product Safety
Vivos Therapeutics hits major milestone with FDA clearance for treating severe sleep apnea
Via News Direct
Exposures Product Safety
Vivos Therapeutics hits major milestone with FDA clearance for treating severe sleep apnea
Via TheNewswire.com
Exposures Product Safety
Yoonpak: Pioneering Paper Cup Manufacturers in Sustainable Packaging
Via AB Newswire
Exposures Product Safety
InvestorNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Releases Shareholder Letter
Via Investor Brand Network
Exposures Product Safety
Tickers PCSA
InvestorNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Announces First-Ever FDA Clearance for Treatment of Severe Obstructive Sleep Apnea Using Oral Device
Via Investor Brand Network
Exposures Product Safety
Tickers VVOS
InvestorNewsBreaks – Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) Updates Special Access Program
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
Tickers MYCOF
Why Is Sleep Disorder Device Provider Vivos Therapeutics Stock Trading Higher Today?
Via Benzinga
Exposures Product Safety
Tickers VVOS
Therma Bright Prepares FDA 513(g) Review Document for its AI-Driven Digital Cough Analyzer (DCA)
Via Newsfile
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
Tickers AAPL TBRIF TSX-V:THRM
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.